100 devices in 7 months: STORZ MEDICAL has successfully launched MAGNETOLITH


In September 2020, the 100th MAGNETOLITH® was ordered and delivered to Dr Damian Görner from the Steglitz Spine and Joints Centre in Berlin. In an interview, the specialist for orthopaedics and trauma surgery explains why he decided to use MAGNETOLITH®, which indications he treats and how EMTT® and ESWT complement each other.


Dr Görner, you’ve been practising extracorporeal shock wave therapy (ESWT) for many years. Why did you decide to start offering extracorporeal magnetotransduction therapy (EMTT®) with MAGNETOLITH® in your range of treatments?
We’ve been routinely successful in treating classic indications with the mechanotransduction induced by radial and focused ESWT in recent years. So the EMTT®, with its active magnetotransduction principle, its highly energetic magnetic field (80 mT), as well as its very high oscillation frequency and penetration depth, complements our therapy portfolio.

Do you treat the same problems with EMTT® and ESWT, or are there differences? Do you see the two therapies as competing or as complementary procedures?
In our practice, we use ESWT for indications of heel spurs (plantar fasciitis), calcific tendinitis of the shoulder and pseudarthrosis. As a shoulder surgeon, I often see focused ESWT replacing surgery for calcific tendinitis. For me, the value of EMTT® is in the treatment of degenerative muscle and tendon pathologies, myofascial pain syndromes, enthesopathies of the joints and degenerative and inflammatory joint conditions. EMTT® is also useful for therapy-resistant lumbar pain syndromes alongside periradicular infiltrations. ESWT and EMTT® go together very well. I even use both methods one after the other, especially for calcific tendinitis of the shoulder.

Which conditions have you mainly treated with EMTT® so far and what are the results?
I currently use EMTT® on the lumbar spine for pain therapy (in combination with acupuncture), for enthesopathies of the elbow joint, calcific tendinitis of the shoulder and plantar fasciitis. For this, we perform EMTT® every 2 days for a total of six treatments. This treatment plan has been the best at reducing pain, letting us reduce patients’ medication, and patients appreciate the relatively short treatment duration with EMTT®. My previous experiences with EMTT® are positive.

Thank you very much for the interview, and wish you all the best for the future.

Further information about EMTT® with MAGNETOLITH® can be found on our website.